<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92-vaccines-07-00053">
 <label>92.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chan</surname>
    <given-names>R.W.</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Karamanska</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Dell</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Haslam</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Sihoe</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Chui</surname>
    <given-names>W.H.</given-names>
   </name>
   <name>
    <surname>Triana-Baltzer</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Q.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>DAS181 inhibits H5N1 influenza virus infection of human lung tissues</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2009</year>
  <volume>53</volume>
  <fpage>3935</fpage>
  <lpage>3941</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00389-09</pub-id>
  <pub-id pub-id-type="pmid">19596886</pub-id>
 </element-citation>
</ref>
